EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps

Blanca Navarro Rodrigo, Yaquelin Ortiz Miranda, Jesús Corria-Osorio, George Coukos, Alexandre Harari

Trends in Cancer · 2025-10 · 11 (10) · 993-1004

DOI: 10.1016/j.trecan.2025.08.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-10. Verfasst von Blanca Navarro Rodrigo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL),…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Neoplasms, Immunotherapy, Adoptive. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-infiltrating lymphocyte (TIL) therapy has emerged as a transformative approach in cancer immunotherapy, particularly following the recent US Food and Drug Administration (FDA) approval of lifileucel for advanced melanoma. This review synthesizes current insights into the immune correlates and mechanisms underlying the efficacy of TIL therapy, highlighting the pivotal role of tumor immunogenicity, TIL functional states, and the tumor microenvironment (TME). Recent advances in single-cell profiling and biomarker discovery have enabled more precise patient selection and therapy optimization, while novel expansion protocols and engineered TILs are addressing resistance and broadening applicability to non-melanoma tumors. Collectively, these developments underscore the promise of next-generation TIL therapies to revolutionize treatment paradigms across a wider spectrum of solid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingNeoplasmsImmunotherapy, AdoptiveHumansTumor MicroenvironmentTreatment OutcomeBiomarkers, TumorAnimals

Stichwörter der Autor:innen

TIL therapyadoptive cell transferbiomarkerscorrelates of efficacytumor-infiltrating lymphocytes

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland; Center for Cell…

Zitieren

APA

Navarro Rodrigo, B., Ortiz Miranda, Y., Corria-Osorio, J., Coukos, G., & Harari, A. (2025). Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps. Trends in Cancer, 11(10), 993-1004. https://doi.org/10.1016/j.trecan.2025.08.002

Vancouver

Navarro Rodrigo B, Ortiz Miranda Y, Corria-Osorio J, Coukos G, Harari A. Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps. Trends in Cancer. 2025;11(10):993-1004. doi:10.1016/j.trecan.2025.08.002

BibTeX
@article{NavarroRodrigo2025,
  author = {Navarro Rodrigo, Blanca and Ortiz Miranda, Yaquelin and Corria-Osorio, Jesús and Coukos, George and Harari, Alexandre},
  title = {Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {10},
  pages = {993--1004},
  doi = {10.1016/j.trecan.2025.08.002}
}
Kostenlos starten →